Enhancing the anti-cancer function of natural killer cells with nanoparticles could unlock their therapeutic potential, according to a Northwestern Medicine study.
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
Measuring levels of hypervigilance and anxiety may improve healthcare providers’ understanding of severe esophageal diseases and treatment strategies, according to a Northwestern Medicine study.
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
Thirty-five years since it was started, the Coronary Artery Risk Development in Young Adults study, or CARDIA, has become a premier source for the determinants, mechanism and outcomes of cardiovascular disease and manifestations of aging.
Children born to women with epilepsy who took anti-seizure medications during pregnancy versus children born to women without epilepsy did not differ in terms of cognitive outcomes and overall neurodevelopment, according to findings published in JAMA Neurology.
Neurons in the hippocampus encode a spatial map of learned knowledge, helping humans and other mammals navigate the world, according to a study published in Nature.
A Northwestern Medicine study has found that women with hormone receptor-positive breast cancer were more likely to discontinue hormone therapy early due to poor quality of life-related outcomes.